Delivery Order SPE2DR25D9131-SPE2DR26FCPB6
- Not listed
- The Defense Logistics Agency awarded a $12,246.58 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 15 mg. This firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and requires fulfillment at the vendor's Park Ridge location. The award carries no set-aside designation, indicating the company competed in...
- The Defense Logistics Agency awarded a $24,293.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packages). The contract, awarded on September 29, 2025, carries a ceiling value of $72,293.40 under a firm fixed-price arrangement with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, valued at $12,115.65, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $24,088.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 26, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace....
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, effective May 30, 2025, carries a ceiling value of $12,146.79 and represents a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. This award was made without set-aside designation, demonstrating the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packaging). The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- SPE2DR25D9131Indefinite Delivery Contract
- SPE2DR25D9131-SPE2DR26FCPB6Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg with a firm fixed price ceiling value of $24,729.64. The award, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was funded by the Defense Logistics Agency and represents performance of work at the contractor's Park Ridge, Illinois location. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products to support Department of Defense military healthcare facilities worldwide. This contract positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, which comprises a 30-month base period with three 30-month option periods.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 10/23/25 |